Skip to main content
2026 CRT Conference Main banner

CRT 2026

Evening Symposium

Session:: Evening Symposium | Optimization of Antiplatelet Therapy for ACS Patients [CME] –Supported Through a by Educational Grant from Chiesi, USA

Panel Discussion

Sunday, March 8, 2026
7:20 PM - 7:30 PM EST
Location: Lincoln

    Moderator(s)

  • Marc Cohen, MD

    Chair of Medicine
    Newark Beth Israel Med Ctr
    Philadelphia, Pennsylvania, United States

    Disclosure(s): BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen, Regeneron: Grant/Research Support (Ongoing)

  • C. Michael Gibson, MD

    Professor of Medicine
    Beth Israel Deaconess Medical Center
    Boston, Massachusetts, United States

    Disclosure(s): Amgen, Chiesi, Angel/Avertix Medical, Anthos Therapeutics, Janssen Pharmaceuticals, Johnson & Johnson Corporation, Bayer Corporation, Corsear, MashUp MD, Bioclinica, MD Magazine, Boehringer Ingelheim, Merck, Boston Clinical Research Institute, MjHeal: Consulting Fees (e.g., advisory boards) (Ongoing); HeartBeam, nference, Flow Therapy, Celecor, Fortress Biotech, TribeMD (Co-Founder), Generable and Lexaria: Stock Options [in privately held companies] (Ongoing); Johnson & Johnson Corporation, CSL Behring, SCAD Alliance, NACAM Trial (Sub-award - 5R01HL151996-05), and Janssen Pharmaceuticals.: Grant/Research Support (Ongoing); UpToDate in Cardiovascular Medicine: Royalties (Ongoing)

  • Neal S. Kleiman, MD, FACC, MSCAI

    Medical Director, Cardiac Catheterization Laboratories
    Houston Methodist DeBakey Heart and Vascular Center
    Houston, Texas, United States

    Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Grant/Research Support (Ongoing)

    • Panel Discussant(s)

  • Usman Baber, MD, MS

    Professor of Medicine
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma, United States

    Disclosure(s): AstraZeneca Pharmaceuticals: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scietific: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • Abhishek Chaturvedi, MD

    Interventional Cardiologist & Assistant Professor of Medicine
    West Virginia University Heart & Vascular Institute, United States

    Disclosure(s): No financial relationships to disclose

  • Madhan Sundaram, MD, FACC, FSCAI

    Associate Professor of Medicine/ Director of Interventional Cardiology
    Banner University Medical Center, Tucson/ University of Arizona
    Tucson, Arizona, United States

    Disclosure(s): No financial relationships to disclose

Disclosure(s):
Marc Cohen, MD: BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen, Regeneron: Grant/Research Support (Ongoing)
C. Michael Gibson, MD: Amgen, Chiesi, Angel/Avertix Medical, Anthos Therapeutics, Janssen Pharmaceuticals, Johnson & Johnson Corporation, Bayer Corporation, Corsear, MashUp MD, Bioclinica, MD Magazine, Boehringer Ingelheim, Merck, Boston Clinical Research Institute, MjHeal: Consulting Fees (e.g., advisory boards) (Ongoing); HeartBeam, nference, Flow Therapy, Celecor, Fortress Biotech, TribeMD (Co-Founder), Generable and Lexaria: Stock Options [in privately held companies] (Ongoing); Johnson & Johnson Corporation, CSL Behring, SCAD Alliance, NACAM Trial (Sub-award - 5R01HL151996-05), and Janssen Pharmaceuticals.: Grant/Research Support (Ongoing); UpToDate in Cardiovascular Medicine: Royalties (Ongoing)
Neal S. Kleiman, MD, FACC, MSCAI: Abbott Vascular, Medtronic, Boston Scientific: Grant/Research Support (Ongoing)
Usman Baber, MD, MS: AstraZeneca Pharmaceuticals: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scietific: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Abhishek Chaturvedi, MD: No financial relationships to disclose
Madhan Sundaram, MD, FACC, FSCAI: No financial relationships to disclose